We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Clinical Investigation Subject definition

Clinical Investigation Subject means a person recruited to participate in the Clinical Investigation.
Sample 1Sample 2Sample 3

Examples of Clinical Investigation Subject in a sentence

  • Any right or remedy of a third party which existed or is available apart from the Third Party Rights Act is not affected; in particular, without limitation, any right of any Clinical Investigation Subject to claim compensation in accordance with the Clinical Investigation Compensation Guidelines referred to in Appendix 3.

  • Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor by the Board save where this is required to satisfy the requirements of the Clinical Investigation Plan or for the purpose of monitoring, auditing or adverse event reporting or investigation, or in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.

  • Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor by the Trust save where this is required to satisfy the requirements of the Clinical Investigation Plan or for the purpose of monitoring, auditing or adverse event reporting or investigation, or in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.

  • The Sponsor shall not disclose the identity of Clinical Investigation Subjects to third parties without prior written consent of the Clinical Investigation Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the NHS Scotland Code of Practice on Protecting Patient Confidentiality (August 2003), unless in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.

  • The Sponsor shall not disclose the identity of Clinical Investigation Subjects to third parties without prior written consent of the Clinical Investigation Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the NHS Confidentiality Code of Practice (November 2003), unless in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.

  • Any right or remedy of a third party which existed or is available apart from the Third Party Right Act is not affected; in particular, without limitation, any right of any Clinical Investigation Subject to claim compensation in accordance with the Clinical Investigation Compensation Guidelines referred to in Appendix 4.

  • Neither the Sponsor nor CRO shall disclose the identity of Clinical Investigation Subjects to third parties without prior written consent of the Clinical Investigation Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the NHS Scotland Code of Practice on Protecting Patient Confidentiality (August 2003), unless in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.

  • Neither the Sponsor nor CRO shall disclose the identity of Clinical Investigation Subjects to third parties without prior written consent of the Clinical Investigation Subject, except in accordance with the provisions of the Data Protection Act 1998 and the principles set out in the NHS Confidentiality Code of Practice (November 2003), unless in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.

  • Personal data (as defined in the Data Protection Act 1998) shall not be disclosed to the Sponsor or CRO by the Trust save where this is required to satisfy the requirements of the Clinical Investigation Plan or for the purpose of monitoring, auditing or adverse event reporting or investigation, or in relation to a claim or proceeding brought by the Clinical Investigation Subject in connection with the Clinical Investigation.

  • The College understands that OCR will not close the monitoring of this Agreement until OCR determines that the College has fulfilled the terms of this Agreement and is in compliance with Section 504 and its implementing regulation at 34 C.F.R. § 104.4, and Title II and its implementing regulation at 28 C.F.R. §§ 35.130 and 35.160, which were at issue in this complaint.

Related to Clinical Investigation Subject

  • clinical investigation means any systematic investigation involving one or more human subjects, undertaken to assess the safety or performance of a device;

  • Background investigation means the investigation conducted by a licensee or applicant to support the determination of trustworthiness and reliability.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Study Subject an individual who participates in the Study, either as a recipient of the Investigational Product (defined below) or as a control. Subjekt studie: jednotlivec, který se účastní Studie, buď jakožto příjemce Hodnoceného léčiva (ve smyslu níže uvedené definice) nebo jako kontrolní subjekt.

  • Remedial investigation means a process to determine the nature and extent of a discharge of a contaminant at a site or a discharge of a contaminant that has migrated or is migrating from the site and the problems presented by a discharge, and may include data collected, site characterization, sampling, monitoring, and the gathering of any other sufficient and relevant information necessary to determine the necessity for remedial action and to support the evaluation of remedial actions if necessary;

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Complaint Investigation means an investigation of any complaint that has been made to a proper authority that is not covered by an abuse investigation.

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Manufacturing Know-How means all information, techniques, inventions, discoveries, improvements, practices, methods, knowledge, skill, experience and other technology, whether or not patentable or copyrightable, and any copyrights based thereon, relating to or necessary or useful for the production, purification, packaging, storage and transportation of Collaboration Products, including without limitation specifications, acceptance criteria, manufacturing batch records, standard operating procedures, engineering plans, installation, operation and process qualification protocols for equipment, validation records, master files submitted to the FDA, process validation reports, environmental monitoring processes, test data including pharmacological, toxicological and clinical test data, cost data and employee training materials.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Pivotal Clinical Trial means a Phase 3 Clinical Trial, or a Phase 2b Clinical Trial for which the applicable Regulatory Authority has determined that the data generated in such Phase 2b Clinical Trial would be sufficient, depending on its outcome, to support the Regulatory Approval for the applicable Licensed Product.

  • Clinical Study means a Xxxxx 0 Xxxxx, Xxxxx 2 Study, Phase 3 Study, Post-Marketing Study, Supplemental Study or other study (including a non-interventional study) in humans to obtain information regarding the product, including information relating to the safety, tolerability, pharmacological activity, pharmacokinetics, dose ranging or efficacy of the product.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Abuse Investigation and Protective Services means reporting and investigation activities as required by OAR 407-045-0300 and any subsequent services or supports necessary to prevent further abuse as required by OAR 407-045-0310.

  • Site investigation means the collection and evaluation of data adequate to determine whether or not discharged contaminants exist at a site or have migrated or are migrating from the site at levels in excess of the applicable remediation standards. A site investigation shall be developed based upon the information collected pursuant to the preliminary assessment;

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase IV Clinical Trial means a post-registrational Clinical Trial conducted in any country or countries and required as a condition to, or for the maintenance of, any Regulatory Approval for a Product in the Territory.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Clinical peer means a physician or other health care professional who holds a non-restricted license in a state of the United States and in the same or similar specialty as typically manages the medical condition, procedure or treatment under review.

Most Referenced Clauses

Most Referenced Definitions